DCR-LLY11

N/A

Report date: 2024/07/23 17:23:35

Base Information

Drug NameDCR-LLY11
Drug Alias NameDCR-LLY11
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionMicrotubule-associated protein tau inhibitorsRNA interference
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDicerna Pharmaceuticals IncEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesDicerna Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A